Ki-Hyun Kim

This inventor holds 1 USPTO granted patent. Top assignee: Seoul National University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki-Hyun Kim. Retrieved from https://idiyas.com/inventor/ki-hyun-kim-yny1sjpr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ki-Hyun Kim

Ki-Hyun Kim is a notable inventor recognized for his contributions to the field of biotechnology. He is currently affiliated with Seoul National University, where he engages in groundbreaking research and development. His work primarily focuses on advancements in medical technology and therapeutic applications.

Latest Patents

Ki-Hyun Kim holds a patent titled "Chimeric Antigen Receptor to Which Anti-Cotinine Antibody is Linked, and Use Thereof." This innovative patent represents a significant step forward in the development of targeted therapies, particularly in the realm of immunology. He has achieved 1 patent that showcases his expertise and commitment to advancing medical science.

Career Highlights

Throughout his career, Ki-Hyun Kim has made substantial contributions to the scientific community. His research has been pivotal in exploring new avenues for treatment and has garnered attention for its potential impact on patient care. His dedication to innovation is evident in his work at Seoul National University, where he collaborates with other leading researchers.

Collaborations

Ki-Hyun Kim has worked alongside his coworker, Hyung-Bae Park, to further enhance the scope of their research. Their collaboration exemplifies the importance of teamwork in scientific discovery and innovation.

Conclusion

In summary, Ki-Hyun Kim is a distinguished inventor whose work at Seoul National University has led to significant advancements in biotechnology. His patent on chimeric antigen receptors highlights his innovative spirit and dedication to improving medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…